BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND FGFR1OP, FOP, 11116, ENSG00000213066 AND Prognosis
3 results:

  • 1. Increase in ADAR1p110 activates the canonical Wnt signaling pathway associated with aggressive phenotype in triple negative breast cancer cells.
    Morales F; Pérez P; Tapia JC; Lobos-González L; Herranz JM; Guevara F; de Santiago PR; Palacios E; Andaur R; Sagredo EA; Marcelain K; Armisén R
    Gene; 2022 Apr; 819():146246. PubMed ID: 35122924
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. HOMER3 facilitates growth factor-mediated β-Catenin tyrosine phosphorylation and activation to promote metastasis in triple negative breast cancer.
    Liu Q; He L; Li S; Li F; Deng G; Huang X; Yang M; Xiao Y; Chen X; Ouyang Y; Chen J; Wu X; Wang X; Song L; Lin C
    J Hematol Oncol; 2021 Jan; 14(1):6. PubMed ID: 33407765
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway.
    Zheng A; Song X; Zhang L; Zhao L; Mao X; Wei M; Jin F
    J Exp Clin Cancer Res; 2019 Jul; 38(1):305. PubMed ID: 31300015
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.